Calamos Advisors LLC raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 0.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 109,512 shares of the company’s stock after purchasing an additional 738 shares during the quarter. Calamos Advisors LLC’s holdings in GE HealthCare Technologies were worth $8,112,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of GEHC. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at approximately $25,000. Gladwyn Financial Advisors Inc. bought a new position in GE HealthCare Technologies during the second quarter valued at approximately $34,000. Game Plan Financial Advisors LLC lifted its stake in GE HealthCare Technologies by 295.3% in the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after acquiring an additional 375 shares during the last quarter. Zions Bancorporation National Association UT bought a new stake in GE HealthCare Technologies in the first quarter worth approximately $42,000. Finally, HFM Investment Advisors LLC acquired a new position in shares of GE HealthCare Technologies during the 1st quarter worth $60,000. 82.06% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
GEHC has been the subject of several analyst reports. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Wells Fargo & Company reduced their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research report on Thursday, October 30th. Barclays initiated coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target for the company. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price objective for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $86.10.
GE HealthCare Technologies Stock Down 1.3%
GEHC opened at $73.97 on Friday. The business has a 50 day moving average of $75.20 and a 200-day moving average of $73.65. The stock has a market capitalization of $33.69 billion, a price-to-earnings ratio of 15.28, a P/E/G ratio of 2.82 and a beta of 1.13. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The business had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. GE HealthCare Technologies’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
- Five stocks we like better than GE HealthCare Technologies
- What is the Dogs of the Dow Strategy? Overview and Examples
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- Stock Market Sectors: What Are They and How Many Are There?
- Ondas Holdings Signals a Rebound as Drone Demand Soars
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Disney’s 2026 Outlook Brightens Under Iger’s Magic Touch
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
